Manfredi Giacomo, Pezzuto F, Balestrieri A, Lo Schiavo M, Montera M C, Pio A, Iannelli M, Gargano D, Bianchi M J, Casale G, Galimberti M, Triggiani M, Piazza O
Religious General Hospital "F. Miulli", Acquaviva (BA), Italy.
Transl Med UniSa. 2013 Sep 2;7:12-7. eCollection 2013.
Basing on the current knowledge, this paper is aimed to review the core characteristics of the most relevant therapeutic agents (steroids and antihistamines), administered to prevent perioperative anaphylaxis. Moreover, the Authors propose the validation of a Global Anaphylactic Risk Score, built up by recording the individual scores related to the most relevant anaphylaxis parameters (i.e. medical history, symptoms and medication for asthma, rhinitis and urticaria etc) and by adding them on all together; the score could be used in the preoperative phase to evaluate the global anaphylactic risk and to prescribe risk-oriented premedication protocols.
基于目前的知识,本文旨在综述用于预防围手术期过敏反应的最相关治疗药物(类固醇和抗组胺药)的核心特征。此外,作者提议验证一个全球过敏风险评分,该评分通过记录与最相关过敏参数(即病史、哮喘、鼻炎和荨麻疹等的症状及用药情况)相关的个体评分并将它们全部相加得出;该评分可在术前阶段用于评估整体过敏风险并制定以风险为导向的术前用药方案。